News and Press Releases
Mogrify appoints Dr Jonathan Appleby as chief scientific officer
Strategic hire bolsters executive leadership team as company progresses multiple therapeutic programmes toward and into clinical development 15 July 2024 – Cambridge, UK – Mogrify, a regenerative medicine company developing...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: July 15, 2024
Deep Genomics Expands Executive Leadership and Operations in Latest Strategic Growth Initiative
Company announces executive new hires and marks significant momentum with Cambridge, Massachusetts, US, site opening and Toronto, Canada, office expansion 13 June 2024 -- Massachusetts, US -- Deep Genomics, the...
Category: Biotechnology, Other, Pharmaceutical
Posted: June 13, 2024
480 University Ave, Suite 1300 Toronto, Ontario, Canada, M5G 1V2
Annogen Announces Research Collaboration with Orchard Therapeutics for the Development of CNS-cell Specific Promoters
Annogen to develop immune cell-specific human promoters for certain Orchard pre-clinical programmes 4 June 2024 -- Amsterdam, The Netherlands -- Annogen, a company with expertise in bespoke promoter design and...
Category: Biotechnology, Drug Discovery, Pharmaceutical
Posted: June 4, 2024
Bionova Scientific announces plans for new Plasmid DNA GMP facility
Facility in The Woodlands, Texas, US, to produce critical starting material for cell and gene therapy, DNA/RNA-based, and recombinant protein therapeutics in Q1/2025 3 June 2024 -- California, US --...
Category: BioManufacturing, Manufacturing and Packing, Pharmaceutical
Posted: June 3, 2024
Cellular Origins and Cell and Gene Therapy Catapult collaborate to demonstrate universal automation of CGT manufacturing
Partnership to develop and implement Cellular Origins’ robotic platform Constellation for universal automation of CGT manufacturing at CGT Catapult’s Stevenage Manufacturing Innovation Centre, UK 29 May 2024 -- Cambridge, UK,...
Category: BioManufacturing, Biotechnology, Drug Discovery
Posted: May 29, 2024
Successful Conclusion of London Biotechnology Show, Leaves Attendees Highly Satisfied
10 May 2024 -- London, UK -- The curtain has closed on the debut London Biotechnology Show 2024, leaving attendees thoroughly impressed by the seamless delivery of promised content and...
Category: Biotechnology
Posted: May 10, 2024
Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness Within 24 Weeks and Initial Hearing Improvements in a Second Child at Six Weeks
Preliminary data detailed in an ASGCT oral presentation include results for one of the youngest children in the world to receive a gene therapy for genetic deafness Ongoing phase 1/2...
Category: Biotechnology, Clinical Trials
Posted: May 8, 2024
The Charter Building, Vine Street, Uxbridge, Middlesex, United Kingdom, UB8 1JG
First Commercial Cell and Gene Therapy Product Manufactured at Minaris Regenerative Medicine in Allendale, New Jersey, US
With the recent FDA approval of LYFGENIA, developed by bluebird bio, Minaris Regenerative Medicine North America is now supporting a commercial cell and gene therapy (CGT) product The first commercial...
Category: BioManufacturing, Biotechnology
Posted: May 8, 2024
Broken String Biosciences and the Francis Crick Institute collaborate to advance ALS research
Partnership to expand applications of DNA break-mapping technology and advance understanding of genomic instability in development of the neurodegenerative disease amyotrophic lateral sclerosis 07 May 2024 -- Cambridge and London,...
Category: Drug Discovery, Pharmaceutical
Posted: May 7, 2024
Unit AB3-04, Level 3 BioData Innovation Centre Wellcome Genome Campus Hinxton Cambridge, CB10 1DR
Revolutionising Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device
First-of-its-kind Cell Factory Box streamlines production, making advanced treatments accessible and affordable 2 May 2024 -- Raleigh, North Carolina -- ProPharma, the leading global provider of regulatory, clinical and compliance services...
Category: BioManufacturing, Clinical Trials, Drug Discovery
Posted: May 2, 2024
Cellular Origins, a TTP Company, appoints Peter Crossley as Chief Operating Officer
Product and technology innovator will build team to further develop and deliver Cellular Origins’ products for cell and gene therapy manufacture at scale 25 January 2024 -- Cambridge, UK --...
Category: BioManufacturing
Posted: January 25, 2024
Broken String Biosciences strengthens senior leadership team to accelerate product development and commercialisation
Appointment of Vincent Smith PhD, as chief technology officer and Jessica Rich as VP of Business Development Follows Broken String’s successful $15m Series A fundraising round in September 2023 Will...
Category: Biotechnology
Posted: October 4, 2023
Unit AB3-04, Level 3 BioData Innovation Centre Wellcome Genome Campus Hinxton Cambridge, CB10 1DR
Broken String Biosciences Closes $15m Series A Funding Round
Funds to support further development and commercialisation of the company’s INDUCE-seq DNA break mapping technology Platform technology provides in situ off-target measurement in clinically relevant cells to accelerate the progression...
Category: Biotechnology
Posted: September 18, 2023
Unit AB3-04, Level 3 BioData Innovation Centre Wellcome Genome Campus Hinxton Cambridge, CB10 1DR
